首页|细辛脑注射液联合雾化吸入及心理干预治疗慢性阻塞性肺疾病急性期疗效及对肺功能的影响

细辛脑注射液联合雾化吸入及心理干预治疗慢性阻塞性肺疾病急性期疗效及对肺功能的影响

扫码查看
目的 观察细辛脑注射液联合雾化吸入及心理干预对慢性阻塞性肺疾病(慢阻肺)急性期的疗效和对患者肺功能的影响.方法 根据《慢性阻塞性肺疾病诊治指南》中关于慢性阻塞性肺疾病急性期的诊断标准筛选出某院心胸外科就诊的81例患者,随机双盲地将其分为观察组40例和对照组41例.给予对照组患者雾化吸入治疗,观察组细辛脑注射液联合雾化吸入进行治疗.于治疗前后测定患者血清白细胞介素-8(IL-8)、干扰素-γ(IFN-γ)、肿瘤坏死因子(TNF-α)水平,使用血气分析仪测定患者动脉血氧分压(PaO2)和动脉血二氧化碳分压(PaCO2)水平,使用肺功能仪测定患者第1秒用力呼吸量占预计值百分比(FEV1% pred)和总气道阻力,根据以上指标判定联合治疗方案和单独治疗方案的疗效对比.结果 ①IL-8、IFN-γ、TNF-α:治疗后观察组明显低于对照组(t=11.498;t=10.279;t=11.576),差异均具有统计学意义(P<0.05).②血气指标PaO2和PaCO2:治疗后观察组明显优于对照组(t=11.021;t=8.868),差异均具有统计学意义(P<0.05).③肺功能指标FEV1%pred和总气道阻力:治疗后观察组明显优于对照组(t=7.182;t=6.341),差异均具有统计学意义(P<0.05).④观察组治疗后总有效率显著高于对照组(χ2=4.742),差异具有统计学意义(P<0.05).结论 细辛脑注射液联合雾化吸入可降低慢性阻塞性肺疾病急性期患者体内炎症水平,调节体内血气指标,改善肺功能,提高慢阻肺急性期患者的治疗效果.
Effect of asarone injection combined with inhalation and psychological intervention on acute lung injury and its effect on pulmonary function
Objective To observe the efficacy of asarone injection combined with inhalation on the treatment of COPD acute phase.MethodsAccording to "chronic obstructive pulmonary disease diagnosis and treatment guidelines"in the diagnostic criteria for chronic obstructive pulmonary disease in acute phase, 81 patients were randomized double-blindly divided into observation group of 40 cases and a control group 41 cases.Administering inhalation nebulizer patients in the control group, asarone injection combined with inhalation treatment in the observation group.Serum levels of interleukin-8 (IL-8), interferon-γ (IFN-γ), tumor necrosis factor (TNF-α) levels before and after treatment, using a blood gas analyzer patients arterial oxygen pressure (PaO2) and arterial carbon dioxide tension (PaCO2) level, measured using a spirometer patients accounted for one second forced expiratory percentage of predicted value (FEV1% pred) and total airway resistance, and a separate determination combination therapy regimen based on the above indicators Comparative efficacy.Results①IL-8, IFN-γ, TNF-α: After treatment, the observation group was significantly lower than the control group (t=11.498;t=10.279;t=11.576), the differences were statistically significant (P<0.05).②blood gas PaO2 and PaCO2: post-treatment observation group than the control group (t=11.021;t =8.868), the differences were statistically significant (P<0.05).③lung function FEV1% pred and total airway resistance: After treatment, the observation group than the control group (t=7.182;t=6.341), the differences were statistically significant (P<0.05).The total effective rate was significantly higher (χ2 =4.742) after ④observation group, the difference was significant (P<0.05).ConclusionAsarone injection combined with inhalation can reduce chronic inflammation in the body in patients with acute obstructive pulmonary disease, the body adjust blood gas, improve lung function, improve the treatment of patients with acute COPD.

asarone injectioninhalationCOPDpsychological interventionchronic obstructive pulmonary disease acute phase

黄淑群、胡小红、李露

展开 >

宁波市第二医院 心胸外科,浙江 宁波 315000

丽水市人民医院,浙江 丽水 323000

细辛脑注射液 雾化吸入 心理干预 慢性阻塞性肺疾病 慢阻肺急性期

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(6)
  • 7
  • 6